Direct medical costs of obesity in the United States and the most populous states

BACKGROUND: After a dramatic increase in prevalence over several decades, obesity has become a major public health crisis in the United States. Research to date has consistently demonstrated a correlation between obesity and higher medical costs for a variety of U.S. subpopulations and specific categories of care. However, by examining associations rather than causal effects, previous studies likely underestimated the effect of obesity on medical expenditures. OBJECTIVE: To estimate the causal effect of obesity on direct medical care costs at the national and state levels. METHODS: This study is a pooled cross-sectional analysis of retrospective data from the 2001-2016 Medical Expenditure Panel Surveys. Adults aged 20-65 years with a biological child living in the household were included in the study sample. Primary outcomes were individual-level medical expenditures due to obesity, overall, as well as separately by type of payer and category of medical care. Results were reported at the national level and separately for the 20 most populous states. The expenditure estimates were obtained from 2-part models of instrumental variables in which the respondent's body mass index (BMI) was instrumented using the BMI of their biological child. RESULTS: Adults with obesity in the United States compared with those with normal weight experienced higher annual medical care costs by $2,505 or 100%, with costs increasing significantly with class of obesity, from 68.4% for class 1 to 233.6% for class 3. The effects of obesity raised costs in every category of care: inpatient, outpatient, and prescription drugs. Increases in medical expenditures due to obesity were higher for adults covered by public health insurance programs ($2,868) than for those having private health insurance ($2,058). In 2016, the aggregate medical cost due to obesity among adults in the United States was $260.6 billion. The increase in individual-level expenditures due to obesity varied considerably by state (e.g., 24.0% in Florida, 66.4% in New York, and 104.9% in Texas). CONCLUSIONS: The 2-part models of instrumental variables, which estimate the causal effects of obesity on direct medical costs, showed that the effect of obesity is greater than suggested by previous studies, which estimated only correlations. Much of the aggregate national cost of obesity-$260.6 billion-represents external costs, providing a rationale for interventions to prevent and reduce obesity. DISCLOSURES: Novo Nordisk financed the development of the study design, analysis, and interpretation of data, as well as writing support of the manuscript. Cawley, Biener, and Meyerhoefer received financial support from Novo Nordisk to conduct the research study on which this manuscript is based. Smolarz and Ramasamy are employees of Novo Nordisk. Ding and Zvenyach have no conflicts to declare. Our research has been presented as a poster at the 2020 Academy Health Annual Research Meeting (Virtual), July 28-August 6, 2020.

Conflict of interest statement

Novo Nordisk financed the development of the study design, analysis, and interpretation of data, as well as writing support of the manuscript. Cawley, Biener, and Meyerhoefer received financial support from Novo Nordisk to conduct the research study on which this manuscript is based. Smolarz and Ramasamy are employees of Novo Nordisk. Ding and Zvenyach have no conflicts to declare.

Our research has been presented as a poster at the 2020 Academy Health Annual Research Meeting (Virtual), July 28-August 6, 2020.

Cited by

Lee HY, Ko SH, Park S, Kim K, Kim SY, Cho IJ, Cho EJ, Kim HC, Park JH, Ryu SK, Moon MK, Ihm SH; Korean Society of Hypertension. Lee HY, et al. Clin Hypertens. 2024 Sep 1;30(1):24. doi: 10.1186/s40885-024-00279-4. Clin Hypertens. 2024. PMID: 39217384 Free PMC article. Review.

Cheah KJ, Manaf ZA, Mat Ludin AF, Razalli NH. Cheah KJ, et al. Digit Health. 2024 Aug 21;10:20552076241258366. doi: 10.1177/20552076241258366. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39184018 Free PMC article. Review.

Choy K, Abbitt D, Kovar A, Jones TS, McCallum M, Thomas EA, Saxon DR, Wikiel KJ, Jones EL. Choy K, et al. Surg Endosc. 2024 Aug 13. doi: 10.1007/s00464-024-11169-z. Online ahead of print. Surg Endosc. 2024. PMID: 39138683

Méndez-Martínez M, Zamilpa A, Zavala-Sánchez MA, Almanza-Pérez JC, Jiménez-Ferrer JE, Herrera-Ruiz M, González-Cortázar M, Cervantes-Torres J, Fragoso G, Rosas-Salgado G. Méndez-Martínez M, et al. PLoS One. 2024 Aug 8;19(8):e0306903. doi: 10.1371/journal.pone.0306903. eCollection 2024. PLoS One. 2024. PMID: 39116155 Free PMC article.

Sharaiha RZ, Wilson EB, Zundel N, Ujiki MB, Dayyeh BKA. Sharaiha RZ, et al. Obes Surg. 2024 Sep;34(9):3275-3284. doi: 10.1007/s11695-024-07324-z. Epub 2024 Aug 7. Obes Surg. 2024. PMID: 39107454 Clinical Trial.

References

1. Revels S, Kumar SAP, Ben-Assuli O. Predicting obesity rate and obesity-related healthcare costs using data analytics. Health Policy Technol. 2017;6(2):198-207.
1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284-91. - PubMed
1. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377-96. - PMC - PubMed
1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief. 2020(360):1-8. - PubMed
1. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673-89. - PMC - PubMed

Direct medical costs of obesity in the United States and the most populous states

Conflict of interest statement

Similar articles

Cited by

References